期刊文献+

人细小病毒B19 VP1独特区蛋白与自身免疫性疾病的研究进展 被引量:1

Relationships between human parvovirus B19 VP1 unique region protein and autoimmune diseases
原文传递
导出
摘要 人细小病毒B19(简称B19病毒)与多种自身免疫性疾病关系密切,这主要缘于其病毒衣壳蛋白。 B19病毒VP1独特区蛋白延伸到病毒衣壳外,有磷脂酶A2位点,含有多个抗原决定簇,可刺激宿主产生自身抗体,诱发和/或加重多种自身免疫性疾病。结合文献和本课题组工作,本文对B19病毒VP1独特区蛋白的生物学特性及其与自身免疫性疾病的关系进行综述,这有助于B19病毒感染的预防和治疗。 Human parvovirus B19, generally referred to as B19 virus, has been closely associated with a variety of different autoimmune diseases due to the features of its capsid protein. B19 virus VP1 unique region protein that has sites of phospholipase A2 and several antigenic determinants is exposed on the outside of the viral capsid protein. As a result of that, B19 virus VP1 unique region protein can stimulate the host to produce autoantibodies, which induces and/or aggravates the autoimmune diseases. The biological characteristics of B19 virus VP1 unique region protein and its relationships with autoimmune diseases are de-scribed in this review based upon the published literatures and the work achieved by our research team. This review will be helpful to the prevention and treatment of B19 virus infection.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2016年第7期545-548,共4页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(81300583) 福建省自然科学基金资助项目(2014J05096) 中国博士后科学基金资助项目(2014M552705) 2013-2014年福建高层次人才访学研修资助项目(闽人办201376号)
关键词 人细小病毒B19 VP1独特区蛋白 自身免疫性疾病 磷脂酶A2 VP1 unique region protein Autoimmune disease
  • 相关文献

参考文献40

  • 1Kakurina N, Kadisa A, Lejnieks A, et al. Use of exploratory fac-tor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19 [ Jl. Medicina(Kaunas), 2015, 51 (1): 18-24.
  • 2Hsu TC, Chiu CC, Chang SC, et al. Human parvovirus B19 VPlu protein as inflammatory mediators induces liver injury in na- ive mice [J]. Virulence, 2016, 7 (2) : 110-118.
  • 3Tzang BS, Tsai CC, Tsay GJ, et al. Anti-human parvovirus BI9 nonstructural protein antibodies in patients with rheumatoid arthri- tis[J]. Clin Chim Acta, 2009, 405 (1-2): 76-82.
  • 4Zakrzewska K, Corcioli F, Carlsen KM, et al. Human parvovirus B19 ( B19V ) infection in systemic sclerosis patients [ J 1. Intervirology, 2009, 52 ( 5 ) : 279-282.
  • 5Ohtsuka T, Yamazaki S. Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue[ J]. Br J Dermatol, 2005, 152(5) : 1078-1080.
  • 6Ohtsuka T, Yamazaki S. Prevalence of human parvovirus B19 component NS1 gene in patients with Henoch-Schonlein purpura and hypersensitivity vasculitis [ Jl. Br J Dermatol, 2005, 152 (5) : 1080-1081.
  • 7Fallahi P, Ferrari SM, Vita R, et al. The role of human parvovir- us B19 and hepatitis C virus in the development of thyroid disor- ders[]]. Rev Endocr Metab Disord, 2016.
  • 8Epub ahead of print. Young NS, Brown KE. Parvovirus B19 [ J]. N Engl J Med, 2004, 350(6) : 586-597.
  • 9Leisi R, Di Tommaso C, Kempf C, et al. The receptor-binding domain in the VP1 u region of parvovirus B19 [ J ]. Viruses, 2016, 8(3) : 61.
  • 10Tzang BS, Tsay GJ, Lee YJ, et al. The association of VP1 unique region protein in acute parvovirus B19 iufection and anti-phospho- lipid antibody production [ J ]. Clin Chim Acta, 2007, 378 (1-2) : 59-65.

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部